Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2010 | 12-2009 | 12-2008 | |
Operating Expenses | 13,550 | 10,116 | 22,897 |
Operating Income | -13,550 | -10,116 | -22,897 |
Interest Expense | 2,404 | 2,083 | 1,127 |
Other Income | -93 | 3 | -1,011 |
Pre-tax Income | -16,047 | -12,196 | -25,035 |
Income Tax | -1,793 | N/A | N/A |
Net Income Continuous | -14,254 | -12,196 | -25,035 |
Net Income | $-14,254 | $-12,196 | $-25,035 |
EPS Basic Total Ops | -5.07 | -9.35 | -20.92 |
EPS Basic Continuous Ops | -3.14 | -7.36 | -16.74 |
EPS Diluted Total Ops | -5.07 | -9.35 | -20.92 |
EPS Diluted Continuous Ops | -3.14 | -7.36 | -16.74 |
EPS Diluted Before Non-Recurring Items | -5.07 | N/A | N/A |
EBITDA(a) | $-13,540 | $-10,087 | $-22,873 |